` Comparison: 006280 vs EXAS - Alpha Spread

006280
vs
EXAS

Over the past 12 months, Green Cross Corp has underperformed EXAS, delivering a return of +17% compared to the EXAS's +4 046% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
006280
EXAS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Intrinsic Value
200 715.05 KRW
Undervaluation 26%
Intrinsic Value
Price
EXAS Intrinsic Value
46.13 USD
Overvaluation 98%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Green Cross Corp
KRX:006280
149 000 KRW
Exact Sciences Corp
NASDAQ:EXAS
1 865.09 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
006280, EXAS

006280
EXAS
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Green Cross Corp
Revenue
Exact Sciences Corp
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
006280, EXAS

006280
EXAS
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Green Cross Corp
KRX:006280
Exact Sciences Corp
NASDAQ:EXAS
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

Green Cross Corp
27.8%
EXAS
69.7%

Operating Margin

Green Cross Corp
3.5%
EXAS
-6.1%

Net Margin

Green Cross Corp
-0.2%
EXAS
-6.4%

FCF Margin

Green Cross Corp
-0.3%
EXAS
8.7%

ROE

Green Cross Corp
-0.4%
EXAS
-8.7%

ROA

Green Cross Corp
-0.2%
EXAS
-3.5%

ROIC

Green Cross Corp
2.2%
EXAS
-4.3%

ROCE

Green Cross Corp
3.6%
EXAS
-3.8%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
006280, EXAS

Loading
006280
EXAS
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
006280, EXAS

Loading
006280
EXAS
Difference
www.alphaspread.com

Performance By Year
006280, EXAS

Loading
006280
EXAS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 006280 to other stocks
PNEXF
Pharnext SCA
More expensive
vs Green Cross Corp
ABBV
Abbvie Inc
More expensive
vs Green Cross Corp
AMGN
Amgen Inc
More expensive
vs Green Cross Corp
GILD
Gilead Sciences Inc
More expensive
vs Green Cross Corp
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett